Severe sepsis and septic shock: review of the literature and emergency department management guidelines.
暂无分享,去创建一个
David T. Huang | S. Trzeciak | T. Osborn | E. Abraham | D. Stevens | D. Talan | G. Moran | H. Nguyen | E. Rivers | F. Abrahamian | H. Bryant Nguyen | Emanuel P. Rivers | David T. Huang | H. Bryant Nguyen | H. B. Nguyen
[1] D. Elston. Community-acquired methicillin-resistant Staphylococcus aureus. , 2007, Journal of the American Academy of Dermatology.
[2] G. Olsen,et al. A New Classification of Parapneumonic Effusions and Empyema , 2007 .
[3] L. McCaig,et al. National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. , 2006, Advance data.
[4] S. Zanotti-Cavazzoni. Corticosteroids for Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis , 2006 .
[5] H. Nguyen,et al. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[6] G. Bernard,et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment* , 2005, Critical care medicine.
[7] R. Rossaint,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005, The New England journal of medicine.
[8] T. Osborn,et al. Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock. , 2005, Annals of emergency medicine.
[9] R. Wunderink,et al. Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study* , 2005, Critical care medicine.
[10] Larry A Nathanson,et al. Serum lactate as a predictor of mortality in emergency department patients with infection. , 2005, Annals of emergency medicine.
[11] F. Sebat,et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. , 2005, Chest.
[12] Daniel Talmor,et al. A blueprint for a sepsis protocol. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[13] D. Talan,et al. Community-associated methicillin-resistant Staphylococcus aureus: is it in your community and should it change practice? , 2005, Annals of emergency medicine.
[14] Arnaldo Dubin,et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. , 2005, Chest.
[15] J. Jorgensen,et al. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] E. Charlebois,et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. , 2004, Annals of emergency medicine.
[17] S. Deventer,et al. Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia , 1996, Intensive Care Medicine.
[18] J. Bruel,et al. Acute abdomen of unknown origin: Impact of CT on diagnosis and management , 2005, Gastrointestinal Radiology.
[19] C. Pradier,et al. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock , 2005, Intensive Care Medicine.
[20] L. Chawla,et al. Lack of equivalence between central and mixed venous oxygen saturation. , 2004, Chest.
[21] J. Marshall,et al. Source control in the management of severe sepsis and septic shock: An evidence-based review , 2004, Critical care medicine.
[22] G. Bernard,et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis * , 2004, Critical care medicine.
[23] S. L. Murphy,et al. Deaths: final data for 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[24] C. Natanson,et al. Recombinant human activated protein C in sepsis: previous concerns and current usage , 2004 .
[25] D. Annane,et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update , 2004, Critical care medicine.
[26] G. Jacobsen,et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock* , 2004, Critical care medicine.
[27] B. Beutler,et al. Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.
[28] W. Harmsen,et al. Optimal testing parameters for blood cultures. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] C. Hartog,et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill , 2004, Intensive Care Medicine.
[30] Robyn Norton,et al. A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .
[31] Amir H Hamrahian,et al. Measurements of serum free cortisol in critically ill patients. , 2004, The New England journal of medicine.
[32] J. Bartlett,et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. , 2004, Archives of internal medicine.
[33] Margaret M Parker,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.
[34] Alain Cariou,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] , 2004, Critical care.
[35] J. Xiang,et al. Cumulative Clinical Trial Experience with Levofloxacin for Patients with Community-Acquired Pneumonia-Associated Pneumococcal Bacteremia , 2004 .
[36] Todd G Nick,et al. Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS). , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[37] J. Bartlett,et al. Pegylated Interferon-alpha Protects Type 1 Pneumocytes Against SARS Coronavirus Infection in Macaques , 2004 .
[38] Steven D. Brown,et al. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01. , 2004, The Journal of infection.
[39] John G. Bartlett,et al. Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] R. Wunderink,et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. , 2003, Chest.
[41] C. Rosenberg,et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. , 2003, Chest.
[42] K. Carroll,et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] G. Pugliese,et al. Outbreaks of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin Infections , 2003, Infection Control & Hospital Epidemiology.
[44] N. H. Steigbigel. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[45] M. Oh,et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] S. Trzeciak,et al. Emergency department overcrowding in the United States: an emerging threat to patient safety and public health , 2003, Emergency medicine journal : EMJ.
[47] C. Sprung,et al. Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone. , 2003, Critical care medicine.
[48] D. Snydman,et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] L. McCaig,et al. National Hospital Ambulatory Medical Care Survey: 2001 emergency department summary. , 2003 .
[50] J. Vincent,et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? , 2003, Critical care medicine.
[51] N. Tritos. Corticosteroid insufficiency in acutely ill patients. , 2003, The New England journal of medicine.
[52] W. Aird. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. , 2003, Blood.
[53] R. Zaragoza,et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[54] D. Cook,et al. Measures, markers, and mediators: Toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000 , 2003, Critical care medicine.
[55] J. Rello,et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.
[56] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[57] A. Evangelista,et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[59] Michael K Gould,et al. Preventing complications of central venous catheterization. , 2003, The New England journal of medicine.
[60] J. Burke,et al. Infection control - a problem for patient safety. , 2003, The New England journal of medicine.
[61] E. Paulson,et al. Clinical practice. Suspected appendicitis. , 2003, The New England journal of medicine.
[62] D. Calfee,et al. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[64] J. Helterbrand,et al. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis , 2003, Critical care medicine.
[65] P. Marik,et al. Adrenal insufficiency during septic shock* , 2003, Critical care medicine.
[66] G. Clermont,et al. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis* , 2003, Critical care medicine.
[67] R. Wunderink,et al. Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni , 2003 .
[68] J. Steingrub. Prompt administration of drotrecogin alfa (activated) is associated with improved survival. , 2003 .
[69] M. Donnino,et al. Cryptic Septic Shock: A Sub-analysis of Early, Goal-Directed Therap , 2003 .
[70] E. Rivers,et al. Early goal-directed therapy prevents organ failure and mortality in severe sepsis and septic shock , 2003 .
[71] D. Williamson,et al. Corticosteroids for patients with septic shock. , 2003, JAMA.
[72] Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. , 2003, MMWR. Morbidity and mortality weekly report.
[73] J. Mylotte,et al. Epidemiology of bloodstream infection in nursing home residents: evaluation in a large cohort from multiple homes. , 2002, Clinical Infectious Diseases.
[74] Daniel J Sexton,et al. Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.
[75] Can Ince,et al. Nitroglycerin in septic shock after intravascular volume resuscitation , 2002, The Lancet.
[76] M. Boissinot,et al. Toward rapid real-time molecular diagnostic to guide smart use of antimicrobials. , 2002, Current opinion in microbiology.
[77] M. Delignette-Muller,et al. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] J. Siegel. Assessing the use of activated protein C in the treatment of severe sepsis. , 2002, The New England journal of medicine.
[79] H. S. Warren,et al. Risks and benefits of activated protein C treatment for severe sepsis. , 2002, The New England journal of medicine.
[80] Cam Donaldson,et al. An economic evaluation of activated protein C treatment for severe sepsis. , 2002, The New England journal of medicine.
[81] J. Vincent,et al. Anemia and blood transfusion in critically ill patients. , 2002, JAMA.
[82] J. Karlowsky,et al. Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States , 2002, Antimicrobial Agents and Chemotherapy.
[83] J. Karlowsky,et al. Longitudinal Assessment of Antipneumococcal Susceptibility in the United States , 2002, Antimicrobial Agents and Chemotherapy.
[84] D. Schwartz,et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[85] A. Shorr,et al. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. , 2002, Chest.
[86] Y. Kupfer,et al. Goal-directed therapy for severe sepsis. , 2002, The New England journal of medicine.
[87] T. Calandra,et al. Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .
[88] P. Cornbleet. Clinical utility of the band count. , 2002, Clinics in laboratory medicine.
[89] A. Evangelista,et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[90] G. Moore,et al. Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study , 2002, BMJ : British Medical Journal.
[91] A. Tunkel,et al. Treatment of bacterial meningitis , 2002, Current infectious disease reports.
[92] C. Esmon. Protein C pathway in sepsis , 2002, Annals of medicine.
[93] M. Fink. Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? , 2002, Critical care clinics.
[94] A. Evangelista,et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. , 2002, International journal of antimicrobial agents.
[95] M. Pfaller,et al. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. , 2001, The American journal of medicine.
[96] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[97] G. Bernard,et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis , 2001, Critical care medicine.
[98] T. Ng,et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. , 2001, The Journal of antimicrobial chemotherapy.
[99] K. Walley,et al. Physiology of vasopressin relevant to management of septic shock. , 2001, Chest.
[100] J. Karlowsky,et al. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. , 2001, International journal of antimicrobial agents.
[101] D. Chittock,et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series , 2001, Intensive Care Medicine.
[102] K. Polderman,et al. Inter-observer variability in APACHE II scoring: effect of strict guidelines and training , 2001, Intensive Care Medicine.
[103] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[104] Derek C. Angus,et al. Epidemiology of sepsis: An update , 2001, Critical care medicine.
[105] W. Stamm,et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[106] S. Wann,et al. Clinical characteristics of emphysematous pyelonephritis. , 2001, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[107] D. Ander,et al. Central venous oxygen saturation monitoring in the critically ill patient , 2001, Current opinion in critical care.
[108] C. Bradley. Activated protein C in severe sepsis. , 2001, Intensive & critical care nursing.
[109] L. Mermel,et al. Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.
[110] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[111] J. Marshall,et al. Source control in the management of sepsis , 2001, Intensive Care Medicine.
[112] T. Calandra,et al. Antibiotics in sepsis , 2001, Intensive Care Medicine.
[113] D. Pinsky,et al. The endothelial response to oxygen deprivation: biology and clinical implications , 2001, Intensive Care Medicine.
[114] M. Fink. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. , 2001, Critical care clinics.
[115] Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. , 2001, MMWR. Morbidity and mortality weekly report.
[116] H. Qiu,et al. Prognostic value of dobutamine stress test in patients with septic shock. , 2001, Acta pharmacologica Sinica.
[117] E. Mylonakis,et al. Infective endocarditis in adults. , 2001, The New England journal of medicine.
[118] M. Cetron,et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.
[119] E. Bouza,et al. Monotherapy versus combination therapy for bacterial infections. , 2000, The Medical clinics of North America.
[120] J. Acar,et al. Antibiotic synergy and antagonism. , 2000, The Medical clinics of North America.
[121] J. Groeneveld. Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? , 2000, Critical care.
[122] B. Littenberg,et al. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. , 2000, Chest.
[123] H. Okabe,et al. Activated Protein C Reduces the Ischemia/Reperfusion-Induced Spinal Cord Injury in Rats by Inhibiting Neutrophil Activation , 2000, Annals of surgery.
[124] X Viviand,et al. Effect of norepinephrine on the outcome of septic shock , 2000, Critical care medicine.
[125] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[126] A. Groeneveld. Tonometry of partial carbon dioxide tension in gastric mucosa: use of saline, buffer solutions, gastric juice or air , 2000, Critical care.
[127] W. Stortenbeek. [Serum lactate levels as an indicator of tissue hypoxia in severely ill patients]. , 2000, Nederlands tijdschrift voor geneeskunde.
[128] A. Wilmer,et al. Thrombocytopenia and prognosis in intensive care , 2000, Critical care medicine.
[129] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[130] J. Bakker,et al. [Serum lactate level as a indicator of tissue hypoxia in severely ill patients]. , 2000, Nederlands tijdschrift voor geneeskunde.
[131] C. Tseng,et al. Emphysematous Pyelonephritis Clinicoradiological Classification, Management, Prognosis, and Pathogenesis , 2002 .
[132] D. Annane,et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.
[133] D. Norman,et al. Fever in the elderly. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[134] A. Bartelink,et al. [Serum lactate level as an indicator of tissue hypoxia in severely ill patients]. , 2000, Nederlands tijdschrift voor geneeskunde.
[135] J. Todd,et al. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. , 1999, The Pediatric infectious disease journal.
[136] R. Grounds,et al. A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock. , 1999, Critical care medicine.
[137] J. Young,et al. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. , 1999, The Journal of trauma.
[138] M. Rodríguez-Carballeira,et al. Emergence and Dissemination of Quinolone-ResistantEscherichia coli in the Community , 1999, Antimicrobial Agents and Chemotherapy.
[139] J. Bourdarias,et al. Clinical Investigations in Critical CarePersistent Preload Defect in Severe Sepsis Despite Fluid Loading: A Longitudinal Echocardiographic Study in Patients With Septic Shock , 1999 .
[140] R. Townsend,et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. , 1999, The Journal of trauma.
[141] J. Barkhausen,et al. Impact of CT in Patients with Sepsis of unknown Origin , 1999, Acta radiologica.
[142] G. Velmahos,et al. Abdominal computed tomography for the diagnosis of intra-abdominal sepsis in critically injured patients: fishing in murky waters. , 1999, Archives of surgery.
[143] D. Low,et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. , 1999 .
[144] D E Low,et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. , 1999, The New England journal of medicine.
[145] C. Riedl,et al. Bacterial Colonization of Ureteral Stents , 1999, European Urology.
[146] S. Opal,et al. Clinical trials for severe sepsis. Past failures, and future hopes. , 1999, Infectious disease clinics of North America.
[147] H. Smithline,et al. Adrenal dysfunction in hemodynamically unstable patients in the emergency department. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[148] M. Haller,et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. , 1999, Critical care medicine.
[149] N. Kuppermann,et al. Immature neutrophils in the blood smears of young febrile children. , 1999, Archives of pediatrics & adolescent medicine.
[150] G. Wells,et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.
[151] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[152] J. E. Carceller. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis , 1999 .
[153] V. Yu,et al. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. , 1999, International journal of antimicrobial agents.
[154] J. Vincent,et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. , 1999, Critical care medicine.
[155] H. Brodt,et al. Influence of antimicrobial treatment on mortality in septicemia. , 1999, Journal of chemotherapy.
[156] D. Cook,et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. , 1999, Critical care medicine.
[157] Leibovici,et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.
[158] T. Dorman,et al. Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. , 1998, Critical care medicine.
[159] C. Roehrborn,et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. , 1998, The Journal of urology.
[160] Edwards Jd,et al. Importance of the sampling site for measurement of mixed venous oxgen saturation in shock , 1998 .
[161] S. Henderson,et al. Bedside emergency department ultrasonography plus radiography of the kidneys, ureters, and bladder vs intravenous pyelography in the evaluation of suspected ureteral colic. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[162] M. Kollef,et al. A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. , 1998, Critical care medicine.
[163] P. Bollaert,et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. , 1998, Critical care medicine.
[164] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.
[165] G. Schierhout,et al. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials , 1998, BMJ.
[166] T. Kossmann,et al. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. , 1998, AJR. American journal of roentgenology.
[167] O. Mimoz,et al. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. , 1998, The Journal of antimicrobial chemotherapy.
[168] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.
[169] J. Edwards,et al. Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. , 1998, Critical care medicine.
[170] M. Haeney. The role of the complement cascade in sepsis. , 1998, The Journal of antimicrobial chemotherapy.
[171] M. Fine,et al. Quality of care, process, and outcomes in elderly patients with pneumonia. , 1997, JAMA.
[172] H. Bruining,et al. Corticosteroid therapy in severe illness. , 1997, The New England journal of medicine.
[173] M. Oz,et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. , 1997, Critical care medicine.
[174] D. Bates,et al. Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.
[175] S. Opal,et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.
[176] A. Friedman,et al. Necrotizing fasciitis: CT characteristics. , 1997, Radiology.
[177] L. Leibovici,et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study , 1997, Antimicrobial agents and chemotherapy.
[178] E. Gallagher,et al. Agreement between peripheral venous and arterial lactate levels. , 1997, Annals of emergency medicine.
[179] C. Ichai,et al. Reliability of anion gap as an indicator of blood lactate in critically ill patients , 1997, Intensive Care Medicine.
[180] Y. S. Zhou,et al. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. , 1997, The Journal of clinical investigation.
[181] G. Bernard,et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.
[182] J. Vincent,et al. Dear SIRS, I'm sorry to say that I don't like you... , 1997, Critical care medicine.
[183] F. Schildberg,et al. Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis , 2000 .
[184] J A Kufera,et al. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. , 1996, Annals of surgery.
[185] M. Grzybowski,et al. Systemic inflammatory response syndrome criteria and lactic acidosis in the detection of critical illness among patients presenting to an emergency department , 1996 .
[186] F Doyon,et al. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. , 1996, American journal of respiratory and critical care medicine.
[187] J. Carlet,et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. , 1996, Critical care medicine.
[188] C. Sprung,et al. Multiple Organ Dysfunction Score , 1996 .
[189] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[190] M. Weinstein. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[191] S. Wilson,et al. Intraabdominal abscesses: image-guided diagnosis and therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[192] S. Willatts,et al. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. , 1996, Critical care medicine.
[193] P. Marik,et al. The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. , 1996, Chest.
[194] M A Basha,et al. Is it time to reposition vasopressors and inotropes in sepsis? , 1996, Critical care medicine.
[195] R. Nowak,et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. , 1996, The American journal of emergency medicine.
[196] J. Vincent,et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. , 1996, American journal of surgery.
[197] J. Ménard,et al. Is presentation of bacteremia in the elderly the same as in younger patients? , 1996, The American journal of medicine.
[198] P. Pelosi,et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. , 1996, The New England journal of medicine.
[199] P. Pelosi,et al. A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients , 1995 .
[200] C. Sprung,et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.
[201] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[202] François Gouin,et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .
[203] J. Dhainaut,et al. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. , 1995, Critical care medicine.
[204] D. Stevens. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. , 1995, Emerging infectious diseases.
[205] S. Piscitelli,et al. Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies , 1995, Pharmacotherapy.
[206] M. Malangoni,et al. Determinants of mortality for necrotizing soft-tissue infections. , 1995, Annals of surgery.
[207] G. Koch,et al. Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial , 1995 .
[208] S. Nasraway,et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.
[209] R. Simon,et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. , 1995, The American journal of medicine.
[210] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[211] E. Fishman,et al. Spiral CT of the kidneys: role in characterization of renal disease. Part I: Nonneoplastic disease. , 1995, Critical reviews in diagnostic imaging.
[212] C. Manthous,et al. The effect of mechanical ventilation on oxygen consumption in critically ill patients. , 1995, American journal of respiratory and critical care medicine.
[213] B. Chernow,et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. , 1994, JAMA.
[214] J. Westengard,et al. Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts. , 1994, American journal of clinical pathology.
[215] G. Gazelle,et al. Abdominal abscess. Imaging and intervention. , 1994, Radiologic clinics of North America.
[216] C. Hinds,et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.
[217] R. F. Johnston,et al. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .
[218] S. Opal,et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.
[219] R. Dalton,et al. Arterial or mixed venous lactate measurement in critically ill children. Is there a difference? , 1994, Acta paediatrica.
[220] S. Opal,et al. Initial evaluation of human recombinant interleukin‐1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open‐label, placebocontrolled multicenter trial , 1994, Critical care medicine.
[221] D. Remick,et al. Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha. , 1994, The Journal of infectious diseases.
[222] R. Novak. The beleaguered band count. , 1993, Clinics in laboratory medicine.
[223] J. Verhoef,et al. The sepsis syndrome in a Dutch university hospital. Clinical observations. , 1993, Archives of internal medicine.
[224] T. Scalea,et al. Lactate clearance and survival following injury. , 1993, The Journal of trauma.
[225] J. Takala,et al. Regional blood flow and oxygen transport in septic shock , 1993, Critical care medicine.
[226] E. Faragher,et al. Influence of cardiac output on the correlation between mixed venous and central venous oxygen saturation. , 1993, British journal of anaesthesia.
[227] L. Mermel,et al. Detection of Bacteremia in Adults: Consequences of Culturing an Inadequate Volume of Blood , 1993, Annals of Internal Medicine.
[228] D. Powars,et al. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[229] L. Papazian,et al. Norepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock , 1993 .
[230] R. Carlson,et al. Fluid resuscitation in circulatory shock. , 1993, Critical care clinics.
[231] O. Goletti,et al. Percutaneous ultrasound‐guided drainage of intra‐abdominal abscesses , 1993, The British journal of surgery.
[232] W. Shoemaker,et al. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness , 1993, Critical care medicine.
[233] L. Papazian,et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? , 1992, Chest.
[234] D. Gerding,et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy , 1992, Antimicrobial Agents and Chemotherapy.
[235] D. Pinsky,et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. , 1992, The Journal of clinical investigation.
[236] M. Stoller,et al. Pyonephrosis: diagnosis and treatment. , 1992, British journal of urology.
[237] G. Guyatt,et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. , 1992, Chest.
[238] K. Cartwright,et al. Early treatment with parenteral penicillin in meningococcal disease. , 1992, BMJ.
[239] J. E. Carceller. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.
[240] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[241] Ó. Bielsa,et al. [Percutaneous drainage of renal and perirenal abscesses]. , 1992, Actas urologicas espanolas.
[242] S. Morris,et al. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. , 1992, The American journal of physiology.
[243] C. Chopin,et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. , 1992, Chest.
[244] R. Light. Pleural diseases. , 1992, Disease-a-month : DM.
[245] M. C. Townsend,et al. Experience with phenylephrine as a component of the pharmacologie support of septic shock , 1991, Critical care medicine.
[246] T. Inamatsu. [Pseudomonas aeruginosa bacteremia]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.
[247] E. Rackow,et al. Pathophysiology and treatment of septic shock. , 1991, JAMA.
[248] L. Nilsson,et al. Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria. , 1991, The Journal of antimicrobial chemotherapy.
[249] B. Allolio,et al. Cortisol response to corticotropin and survival in septic shock , 1991, The Lancet.
[250] D. Ashbaugh,et al. Empyema thoracis. Factors influencing morbidity and mortality. , 1991, Chest.
[251] J. Parrillo,et al. Cardiovascular dysfunction in septic shock. , 1991, Chest.
[252] M. C. Townsend,et al. High-Dose Phenylephrine Infusion in the Hemodynamic Support of Septic Shock , 1990, DICP : the annals of pharmacotherapy.
[253] K. Marotti,et al. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene , 1990, Nature.
[254] J. Cronan,et al. Percutaneous drainage of renal and perirenal abscesses: results in 30 patients. , 1990, AJR. American journal of roentgenology.
[255] W. Köhler. Streptococcal toxic shock syndrome. , 1990, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[256] P. Papadakos,et al. Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients. , 1989, Critical care medicine.
[257] E. Lang. Renal, perirenal, and pararenal abscesses: percutaneous drainage. , 1990, Radiology.
[258] V. Yu,et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. , 1989, The American journal of medicine.
[259] D. Amsterdam. The development of resistance during antimicrobial therapy , 1989 .
[260] S. Cain,et al. Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. , 1989, Chest.
[261] B. Meyers,et al. Bloodstream infections in the elderly. , 1989, The American journal of medicine.
[262] W. Shoemaker,et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.
[263] M. Weil,et al. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. , 1988, Critical care medicine.
[264] T. Scalea,et al. Central venous blood oxygen saturation: an early, accurate measurement of volume during hemorrhage. , 1986, The Journal of trauma.
[265] J W Warren,et al. Catheter-associated urinary tract infections. , 2012, Critical care nurse.
[266] D Greenwood,et al. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. , 1987, The Quarterly journal of medicine.
[267] M. Weil,et al. Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. , 1987, Critical care medicine.
[268] A. Chang,et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.
[269] M. Aronson,et al. Diagnostic Decision: Blood Cultures , 1987 .
[270] K. Lobdell,et al. Splanchnic and total body oxygen consumption differences in septic and injured patients. , 1987, Surgery.
[271] D. Sackett,et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. , 1989, Chest.
[272] D. Ilstrup,et al. Blood cultures: issues and controversies. , 1986, Reviews of infectious diseases.
[273] P. Gennis,et al. The clinical utility of the leukocyte differential in emergency medicine. , 1986, American journal of clinical pathology.
[274] M. Callaham. Inaccuracy and expense of the leukocyte count in making urgent clinical decisions. , 1986, Annals of emergency medicine.
[275] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[276] J. Shelhamer,et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. , 1985, The Journal of clinical investigation.
[277] J. McCue. Improved mortality in gram-negative bacillary bacteremia. , 1985, Archives of internal medicine.
[278] H. Eichler,et al. Effect of Ketanserin on Phenylephrine‐Dependent Changes in Splanchnic Hemodynamics and Systemic Blood Pressure in Healthy Subjects , 1985, Journal of cardiovascular pharmacology.
[279] J. Parrillo. Cardiovascular dysfunction in septic shock: new insights into a deadly disease. , 1985, International journal of cardiology.
[280] Morris Dl,et al. Hemodynamic Characteristics of Patients with Hypothermia Due to Occult Infection and Other Causes , 1985 .
[281] M. Sande,et al. Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes. , 1985, Annals of internal medicine.
[282] Z. Barbaric. Percutaneous nephrostomy for urinary tract obstruction. , 1984, AJR. American journal of roentgenology.
[283] J. Vincent,et al. Serial lactate determinations during circulatory shock , 1983, Critical care medicine.
[284] M. Weinstein,et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. , 1983, Reviews of infectious diseases.
[285] M. Weinstein,et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. , 1983, Reviews of infectious diseases.
[286] S. Gerzof. Percutaneous drainage of renal and perinephric abscess , 1981, Urologic radiology.
[287] P. Koehler,et al. Diagnosis of abdominal abscesses with computed tomography, ultrasound, and 111In leukocyte scans. , 1980, Radiology.
[288] W. R. Mccabe,et al. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. , 1980, The American journal of medicine.
[289] J. Fisher,et al. Necrotizing fasciitis. Importance of roentgenographic studies for soft-tissue gas. , 1979, JAMA.
[290] P. Gross,et al. Bacteremia in a community hospital: spectrum and mortality. , 1977, Archives of internal medicine.
[291] A. Chow,et al. Clindamycin for treatment of sepsis caused by decubitus ulcers. , 1977, The Journal of infectious diseases.
[292] A. Chow,et al. Sepsis associated with decubitus ulcers. , 1976, The American journal of medicine.
[293] W. Schumer. Steroids in the Treatment of Clinical Septic Shock , 1976, Annals of surgery.
[294] Joseph Lee,et al. Central Venous Oxygen Saturation in Shock: A Study in Man , 1972, Anesthesiology.
[295] A. Medeiros,et al. Recent experience with bacillemia due to gram-negative organisms. , 1971, The Journal of infectious diseases.
[296] R. Bryant,et al. Factors affecting mortality of gram-negative rod bacteremia. , 1971, Archives of internal medicine.
[297] E. Rapaport,et al. Critical Assessment of Use of Central Venous Oxygen Saturation as a Mirror of Mixed Venous Oxygen in Severely Ill Cardiac Patients , 1969, Circulation.
[298] H. Dupont,et al. INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966 , 1969, Medicine.
[299] J. Lewis,et al. Gram-negative bacteremia. , 1969, The Johns Hopkins medical journal.
[300] D. Harrison,et al. Measurement of Central Venous Oxygen Saturation in Patients with Myocardial Infarction , 1968, Circulation.
[301] K. Vosti,et al. The importance of underlying disease in patients with gram-negative bacteremia. , 1968, Archives of internal medicine.
[302] E. Frank. A SHOCK TEAM IN A GENERAL HOSPITAL , 1967, Anesthesia and analgesia.
[303] G. Jackson,et al. Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .
[304] R. Fairbrother. Blood cultures. , 1949, The Practitioner.